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Stent retrievers have become valuable as thrombectomy devices for the treatment of acute ischemic stroke. The rea-
sons for this are 3-fold. First, stent retrievers restore perfusion 
in the occluded vascular territory immediately after insertion. 
Second, they can readily be retrieved and achieve a high rate 
of vessel recanalization, and third, unlike traditional stents, 
they are not permanently deployed and do not have device-
related adverse events in the long term. The Solitaire FR (ev3-
Covidien, Irvine, CA) was the first dedicated stent retriever, 
commercially introduced in Europe in November 2009. The 
percentage of patients with successful reperfusion with the 
Solitaire retriever was higher (64%–100%)1–14 than after phar-
macological intra-arterial thrombolysis (63.2%) or intravenous 
thrombolysis (46.2%).15 After stent retriever thrombectomy, 
favorable clinical outcomes were achieved in ≤77% of patients 
with anterior circulation strokes.16 However, most studies using 
the Solitaire excluded patients with expected high risk for 
adverse outcome and patients with only mild stroke symptoms 
(ie, patients whose treatment was not advised according to con-
temporary guidelines).3–5,9,11,14,16–20 Thus, safety and outcome of 
stent retriever thrombectomy in patients who do not meet stan-
dard inclusion criteria for endovascular stroke treatment are 
not known. The aim of this study was to analyze safety and 
outcome of Solitaire treatment in a large cohort of patients with 
anterior circulation stroke and to compare patients with and 
without risk factors that presumably predict adverse outcomes.
Patients and Methods
Patients with acute stroke admitted to our stroke center are continu-
ously recorded in the Bernese Stroke Registry. In this analysis, we 
Background and Purpose—Stent retrievers have become an important tool for the treatment of acute ischemic stroke. The 
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assessed clinical outcome, procedural characteristics, and peripro-
cedural complications in all patients with anterior circulation stroke 
who were treated with the Solitaire FR stent retriever. Part of the data 
of 49 patients has been included into retrospective and prospective 
international studies on thrombectomy.12,14,21 The study was approved 
by our institutional review board.
Preinterventional Patient Assessment
Neurological deficits were scored by a neurologist using the National 
Institutes of Health Stroke Scale (NIHSS). Baseline demographic and 
clinical data were recorded prospectively.
Computed tomography (CT) or MRI of the head was performed 
before therapy, including CT angiography or contrast-enhanced MR 
angiography depicting the aortic arch and the neck and intracranial 
vessels. Images were assessed for extensive early ischemic signs in 
the middle cerebral artery (MCA) territory, defined as an Alberta 
Stroke Program Early CT Score (ASPECT) of ≤6 on CT, or <5 on 
diffusion-weighted imaging on MRI.14,22 When both pretreatment CT 
and MRI were available, the MRI ASPECT score was used for clas-
sification of infarct size.
Therapy
Criteria for endovascular therapy were an acute neurological deficit 
of <24 hours duration and an NIHSS score ≥4 or isolated aphasia. In 
addition, the causative vessel occlusion had to be accessible by an 
endovascular route, intracranial hemorrhage had to be excluded on 
admission CT or MRI, and clinical and laboratory findings advising 
against endovascular therapy had to be absent. Endovascular strategy 
was based on clinical data and multimodal CT or MRI.
Endovascular therapy was performed under general anesthesia or 
conscious sedation with monitored anesthesia care. High-resolution, 
biplane flat panel diagnostic 4-vessel cerebral angiography was per-
formed before endovascular treatment (Axiom Artis zee; Siemens, 
Erlangen, Germany). The site of vessel occlusion was categorized as 
internal carotid artery (ICA), tandem (ICA in combination with MCA 
and/or anterior cerebral artery), carotid-T, M1 segment of MCA, M2 
segment of MCA, and multiple (MCA in combination with anterior 
cerebral artery). Characteristics from endovascular therapy were 
assessed by review of digital subtraction angiography series and writ-
ten reports.
Leptomeningeal collaterals supplying the occluded vessel territory 
were graded as poor if no angiographically relevant collaterals were 
visualized, as moderate if minimal leptomeningeal anastomoses were 
visualized, and as good if leptomeningeal anastomoses were filling 
the occluded vessel territory by more than half.
Retrieval of the stent was performed in flow arrest using a balloon-
mounted guiding catheter placed with its tip as close as possible to 
the skull base, to prevent the ICA from collapsing during aspiration. 
Triple-access catheter technique was used if the artery to access the 
thrombus was extremely tortuous or large arterial branches origi-
nated between the balloon catheter and the thrombus (Figure). Using 
this technique, a high volume 5 or 6F distal access and aspiration 
catheter was advanced over the wire of the stent retriever in front 
of the occlusion site. The extraction of the clot and stent was per-
formed under simultaneous aspiration at the distal access and infla-
tion of the balloon catheter. In addition to thrombectomy with the 
Solitaire, thromboaspiration with a distal access catheter and simul-
taneous aspiration with a balloon catheter if applicable, intra-arterial 
thrombolysis, percutaneous transluminal angioplasty, or intracranial 
or extracranial stent placement were used in individual patients as 
deemed necessary.
In patients with tandem occlusions, we preferentially performed 
stenting after distal thrombectomy as the last step, using a distal pro-
tection system. In this way, distal thrombectomy of the MCA or distal 
ICA can be performed in flow arrest caused by the more proximal 
ICA occlusion. To avoid stent-associated complications, we usually 
performed percutaneous transluminal angioplasty alone and contin-
ued with stenting only, if rapid reocclusion occurred. Patency of the 
carotid bifurcation, with or without stenting, was closely bedside 
monitored in the stroke unit using Doppler ultrasound.
Intraprocedural complications included vessel wall dissection, ves-
sel perforation, severe vasospasm, in-stent thrombosis, device failure, 
embolization, and immediate reperfusion hemorrhage. Severe vaso-
spasm was defined as vasospasm necessitating intra-arterial spasmol-
ysis using nimodipine or papaverine. Symptomatic intraprocedural 
complications were defined as adverse events associated with an in-
crease in NIHSS score of ≥4 points or death at 24 hours.
Figure. A 53-year-old woman 
with proximal right middle 
cerebral artery (MCA) occlusion 
with dysarthria and left-sided 
hemiparesis (National Insti-
tutes of Health Stroke Scale 
[NIHSS] score, 15). Preinter-
ventional MR perfusion shows 
decreased cerebral blood flow 
and increased time to peak of 
almost the entire MCA territory 
(A and A') in contrast to small, 
scattered lesions on diffusion-
weighted imaging (B) and 
apparent diffusion coefficient 
maps (B'). Digital subtraction 
angiography (lateral projection; 
C) confirms proximal M1 occlu-
sion and persistent trigeminal 
artery (black arrow). Roadmap 
with deployed Solitaire stent 
(white arrow at distal end) 
and 5F aspiration catheter 
in the proximal M1 segment 
(anteroposterior projection; 
D), protecting the trigeminal 
artery from any displacement 
of thrombotic material during 
stent retrieval. NIHSS score 
after 1 day was 4 and outcome 
at 3 months was favorable 
(modified Rankin Scale, 1).
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Cerebral reperfusion was assessed at the end of the endovascular 
procedure, using biplane or 3-dimensional rotational angiography, 
according to the thrombolysis in cerebral infarction grading system.23
Postinterventional Patient Assessment
A CT or MRI was obtained 24 to 72 hours after treatment, or earlier 
in case of clinical deterioration. The occurrence of symptomatic in-
tracranial hemorrhages (sICH) or asymptomatic intracranial hemor-
rhages within 72 hours from stroke onset was recorded according to 
the Prolyse in Acute Cerebral Thromboembolism (PROACT) II crite-
ria.24 Clinical outcome was assessed 3 months after stroke using the 
modified Rankin Scale (mRS).
Statistical Analysis
Categorical variables were compared with the 2-tailed Fisher exact 
test. To determine the predictors of clinical outcome, death, and 
reperfusion success, a forward stepwise logistic regression includ-
ing all variables with a P<0.2 in univariate analysis was performed. 
These variables were age, sex, baseline NIHSS score, occlusion site, 
degree of collaterals, ASPECT score, time from symptom onset to 
arterial puncture, anesthesia type, reperfusion success, symptom-
atic intraprocedural complication, peri-interventional intramural 
arterial dissection, atrial fibrillation, diabetes mellitus, arterial hy-
pertension, hypercholesterolemia, coronary artery disease, previous 
stroke, current or previous smoking, and family history of stroke. 
Successful reperfusion was defined as thrombolysis in cerebral in-
farction grades 2b and 3. Clinical outcome was dichotomized into 
favorable functional outcome (mRS, 0–2) and poor outcome (mRS, 
3–6). Patients with baseline NIHSS score <8 or >30, patients aged 
≥80 years, patients with extensive ischemic signs in the MCA ter-
ritory, or patients with time from symptom onset to endovascular 
intervention >8 hours were assigned to the group who did not meet 
standard inclusion criteria. Patients with missing data on one of these 
criteria were excluded from stratification. A P value of <0.05 was 
considered significant. Statistics were performed with SPSS version 
21 (IBM Corp, Armonk, NY).
Results
From January 2010 to November 2012, 510 patients received 
endovascular treatment for acute ischemic stroke. A total of 
227 patients were treated with the Solitaire stent retriever 
and were included in this study. Pretreatment imaging was 
performed by MRI in 125 (55.1%), CT in 74 (32.6%), and 
both MRI and CT in 27 patients (11.9%). One patient had 
a stroke during percutaneous aortic valve replacement and 
pretreatment CT or MRI was not performed. In 79 patients 
(34.8%), endovascular treatment was performed after intra-
venous thrombolysis with recombinant tissue-type plasmino-
gen activator (median recombinant tissue-type plasminogen 
activator dose, 47 mg; range, 30–77). Baseline characteris-
tics are shown in Table 1. Eighty-one patients (35.7%) met 
standard inclusion criteria for endovascular stroke treat-
ment. Hundred forty-five patients (63.9%) did not fulfill all 
criteria, and 35 of them violated >1 criterion. Vascular risk 
factors were similar in patients meeting standard inclusion 
criteria and those who did not.
Baseline ASPECT scores and extent of leptomenin-
geal collaterals are given in Table I in the online-only Data 
Supplement. Collateral status could not be determined in 1 
patient with carotid-T occlusion because angiograms of the 
contralateral side were missing. Patients presenting with a 
baseline NIHSS score <8 had significantly better collateral 
supply than patients with an NIHSS score ≥8 (P=0.028), and 
patients with extensive ischemic signs in the MCA territory 
had significantly worse collaterals compared with those with 
less extensive ischemic changes (P<0.001).
Procedural Characteristics
Of the 227 patients included in the study, 105 (46.3%) were 
treated with the Solitaire alone. In 122 patients (53.7%), 
additional techniques were used. In patients treated with 
the Solitaire alone, the median procedure time was 44 min-
utes (range, 15–171) versus 114 minutes (range, 31–282) in 
patients receiving multimodal endovascular therapy. In 225 
patients (99.1%), the Solitaire could be deployed over the 
thrombus. In 2 patients, the Solitaire could not be completely 
passed over the thrombus because of elongated vessels. The 
median number of passes by the stent retriever was 1 (range, 
1–6). An immediate bypass effect, restoring at least a trickle 
of flow through the occluded vessel after temporary deploy-
ment of the stent retriever, was seen in 184 patients (81.4%). 










Age ≥80 y  
(n=50)
Extensive Ischemic 
Signs in MCA Territory 
(n=69)
Time From Symptom 
Onset to Arterial 
Puncture >8 h (n=22)
Age, y, mean (SD) 68.2 (14.7) 66.5 (12.5) 65.5 (14.5) 59.4 (13.8) 83.6 (2.6) 65.1 (16.0) 67.1 (14.5)
Women, n (%) 111 (48.9) 35 (43.2) 15 (55.6) 7 (63.6) 30 (60.0) 32 (46.4) 10 (45.5)
Baseline NIHSS score, median 
(range)
16 (2–36) 15 (8–26) 6 (2–7) 36 (36–36) 17.5 (4–36) 20 (6–36) 16.5 (8–22)
Extensive ischemic signs in MCA 
territory, n (%)
69/226 (30.5) 0 (0.0) 2 (7.4) 6 (54.5) 13 (26.0) 69 (100) 5 (22.7)
Occlusion site, n (%)
  Internal carotid artery 2 (0.9) 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.4) 0 (0.0)
  Carotid-T 42 (18.5) 11 (13.6) 1 (3.7) 3 (27.3) 11 (22.0) 22 (31.9) 3 (13.6)
  Tandem occlusion 25 (11.0) 11 (13.6) 3 (11.1) 0 (0.0) 3 (6.0) 6 (8.7) 6 (27.3)
  MCA M1 135 (59.5) 55 (67.9) 18 (66.7) 6 (54.5) 29 (58.0) 34 (49.3) 11 (50.0)
  MCA M2 12 (5.3) 1 (1.2) 5 (18.5) 1 (9.1) 4 (8.0) 1 (1.4) 1 (4.5)
  Multiple occlusions 11 (4.8) 2 (2.5) 0 (0.0) 1 (9.1) 3 (6.0) 5 (7.2) 1 (4.5)
MCA indicates middle cerebral artery; and NIHSS, National Institutes of Health Stroke Scale.
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In 85.5% of all interventions, the Solitaire FR 4×20 mm was 
used, in 10.1% the Solitaire FR 6×30 mm, and in 4.4% both 
were used. In 161 patients (70.9%), successful reperfusion 
(thrombolysis in cerebral infarction, 2b–3) was achieved 
(Table 2; Table II in the online-only Data Supplement).
In multiregression analysis, more extensive leptomeningeal 
collaterals (P=0.011; odds ratio [OR], 1.716; 95% confidence 
interval [CI], 1.131–2.604) predicted successful reperfusion 
independently.
In the majority of patients, endovascular interventions 
were performed under general anesthesia (n=196 [86.3%]). 
Good outcome (mRS, 0–2) was more often in patients under-
going treatment with conscious sedation compared with 
patients receiving general anesthesia (n=19/31 [61.3%] versus 
n=53/190 [36.3%]; P=0.010).
Intraprocedural Complications
In 74 patients (32.6%), 84 intraprocedural complications 
occurred (Table III in the online-only Data Supplement). Nine 
patients (4.0%) had clinically symptomatic complications. 
Most of the symptomatic complications were related to prob-
lems in the cervical ICA such as iatrogenic dissection (n=3) or 
in-stent thrombosis (n=3).
Vessel perforation was observed in 2 patients (1 M1 and 
1 M2 perforation). Bleeding stopped spontaneously in the 
patient with the M1 perforation after retraction of the stent 
retriever, and we were able to stop the bleeding in the patient 
with the M2 perforation by superselective occlusion of 
the MCA branch with a drop of glue (Histoacryl; B. Braun 
Melsungen AG, Melsungen, Germany). In both patients, fol-
low-up CT on the next day showed no extension of the sub-
arachnoid hemorrhage. Material failure occurred in 1 patient 
in whom the stent was lost from the push wire during retrac-
tion in the M1 segment. Treatment with aspirin and Plavix 
was initiated. The vessel remained open, and the patient 
experienced no new symptoms. After recanalization and stent 
placement in ICA occlusions, immediate in-stent thrombo-
sis was seen in 8 of 36 patients (22.2%; Precise; Cordis, a 
Johnson & Johnson company, Miami Lakes, FL, and Cristallo 
Ideale; Invatec S.p.A., Roncadelle, Italy). In-stent thrombo-
sis was successfully treated in all patients with intra-arterial 
Abciximab (ReoPro; Centocor B.V., Leiden, The Netherlands) 
or heparin. No in-stent thrombosis occurred after permanent 
Solitaire deployment. Distal clot embolization was observed 
in 15 patients (6.6%). Six embolizations occurred in a previ-
ously uninvolved vascular territory.
Clinical Outcome and Bleeding Complications
Follow-up imaging with CT or MRI within 72 hours was per-
formed in 225 patients (99.1%). sICH occurred in 22 patients 
(9.7%) and asymptomatic intracranial hemorrhage in 34 
(15.0%; Table 3). Of 18 anticoagulated patients with an inter-
national normalized ratio ≥1.7, sICH occurred in 4 (22.2%), 
whereas only 18 of 207 patients (8.7%) with an international 
normalized ratio <1.7 had an sICH. At 3 months, 221 patients 
(97.4%) underwent assessment of the mRS. Outcome was 
favorable (mRS, 0–2) in 88 patients (39.8%) and poor (mRS, 
3–6) in 133 patients (60.2%).
Multiregression analysis demonstrated successful reper-
fusion (P=0.012; OR, 2.790; 95% CI, 1.254–6.209), higher 
ASPECT score (P=0.037; OR, 1.190; 95% CI, 1.011–1.402), 
younger age (P<0.001; OR, 0.935; 95% CI, 0.908–0.963), 
lower NIHSS score on admission (P<0.001; OR, 0.834; 95% 
CI, 0.781–0.890), and absence of diabetes mellitus (P=0.018; 
OR, 0.284; 95% CI, 0.100–0.806) to be independent predic-
tors of favorable clinical outcome.
Mortality at 3 months was 25.7% (n=57/222). Failed 
reperfusion (P=0.005; OR, 0.354; 95% CI, 0.172–0.729), 
advancing age (P=0.001; OR, 1.056; 95% CI, 1.023–1.091), 
higher NIHSS score on admission (P<0.001; OR, 1.120; 
95% CI, 1.062–1.181), and diabetes mellitus (P=0.001; OR, 
4.375; 95% CI, 1.855–10.320) were independent predictors 
of death. Carotid-T occlusions showed the highest mortality 
rate (39.0%).
Comparison of Patients Who Met Standard 
Inclusion Criteria With Those Who Did Not
Successful reperfusion was achieved in 71% of patients not 
fulfilling standard inclusion criteria, which is similar to the 
70.4% in the group who met the criteria (P=1.000). Outcome 
was favorable (mRS, 0–2) in 57.7% of patients who met 
standard inclusion criteria and in 30.3% of those who did 
not (P<0.001). The rates for sICH were 3.7% and 13.2% 
(P=0.021), for death 11.4% and 33.8% (P<0.001), and for 






NIHSS <8  
(n=27)
NIHSS >30  
(n=11)
Age ≥80 y  
(n=50)
Extensive Ischemic 
Signs in MCA 
Territory (n=69)
Time From Symptom 
Onset to Arterial 
Puncture >8 h (n=22)
Time from symptom onset 
to arterial puncture, min, 
median (range)
235 (64–1426) 222 (110–472) 253 (115–437) 218 (155–370) 233.5 (120–594) 229 (120–778) 621 (494–1426)
Time from arterial puncture 
to final reperfusion, min, 
median (range)
79 (15–282) 81 (16–213) 54 (23–173) 86 (26–282) 61 (21–261) 84 (23–241) 76 (15–196)
Successful reperfusion (TICI, 
2b–3), n (%)
161 (70.9) 57 (70.4) 23 (85.2) 7 (63.6) 37 (74.0) 43 (62.3) 15 (68.2)
Multimodal endovascular 
therapy, n (%)
122 (53.7) 44 (54.3) 13 (48.1) 6 (54.5) 24 (48.0) 39 (56.5) 13 (59.1)
MCA indicates middle cerebral artery; NIHSS indicates National Institutes of Health Stroke Scale; and TICI, thrombolysis in cerebral infarction.
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symptomatic intraprocedural complications 2.5% and 4.8% 
(P=0.709), respectively.
Patients of old age (≥80 years) reached a favorable outcome 
in a low percentage (n=5/49 [10.2%]; P<0.001). Low rates of 
good outcome were also observed in patients with extensive 
ischemic signs in the MCA territory on admission (n=14/68 
[20.6%]; P<0.001) and patients with baseline NIHSS score 
>30 (n=1/10 [10.0%]; P=0.054). The highest mortality rates 
occurred in patients of old age (n=22/49 [44.9%]; P=0.001), 
those, who had extensive ischemic lesions on initial imaging 
(n=29/68 [42.6%]; P<0.001), and patients with high baseline 
NIHSS score (n=5/10 [50.0%]; P=0.129). Figures I and II 
in the online-only Data Supplement give an overview of the 
distribution of mRS scores in patients of old age compared 
with those who were younger and of patients with extensive 
ischemic signs in the MCA territory compared with those 
without, respectively. The percentage of patients with mod-
erately severe to severe disability (mRS, 4–5) in the elderly 
population was not significantly different from that in 
younger patients (n=10/49 [20.4%] versus 25/173 [14.5%]; 
P=0.375). Similar rates of moderately severe to severe dis-
ability were observed in patients with extensive ischemic 
signs compared with those without (n=11/68 [16.2%] versus 
24/152 [15.8%]; P=1.000).
Patients who received endovascular treatment >8 hours 
after stroke onset had comparable rates of good outcome 
(P=0.821) and mortality (P=0.607) as those whose treatment 
began ≤8 hours after ictus.
Discussion
Thrombectomy with the Solitaire proved to be highly effective 
in our 81 patients with acute ischemic stroke of the anterior 
circulation and a median baseline NIHSS score of 15 who met 
standard inclusion criteria for endovascular stroke treatment. 
Reperfusion was successful in 70.4%, outcome was favorable 
in 57.7%, survival at 3 months was 88.6%, and symptomatic 
intraprocedural complications occurred in only 2.5%.
Successful reperfusion in patients fulfilling standard inclu-
sion criteria was similar to previous studies (64%–100%).1–14 
Previously reported favorable clinical outcomes ranged from 
29% to 77%, depending mainly on whether patients with pos-
terior circulation strokes were included. The median NIHSS 
scores in these studies were generally high (median NIHSS 
scores, 15–38).2,4,7,9,11,12,14,16,17,21
Several previous studies with the Solitaire stent retriever 
excluded patients with an expected low chance of a favorable 
outcome (ie, patients with baseline NIHSS score >30, patients 
≥80 years, patients with extensive ischemic signs in the 
MCA territory and patients treated >8 hours after symptom 
onset).3–5,9,11,14,16–19 Notably, more than half of the patients 
in our series (64.1%) did not meet standard criteria. As this 
patient population generally constitutes a large part of patients 
treated at high-volume stroke centers, findings on outcome in 
this group are of particular importance.
Successful reperfusion rate in elderly patients was similar 
to that in younger patients. This indicates that age-related ath-
erosclerotic changes do not influence technical success with 
the Solitaire, but favorable outcome (10.2%) and survival 
(55.1%) in patients ≥80 years of age were lower than in the 
younger cohort. Similar results were found in a retrospective 
comparison of patients ≥80 years of age and younger patients 
undergoing endovascular treatment for acute ischemic stroke.25 
It remains unknown what effect successful reperfusion in the 
elderly has on clinical outcome. IST-3 revealed similar treat-
ment effects of intravenous thrombolysis in patients >80 years 
of age compared to younger patients, despite a generally worse 
outcome in the elderly.26 It also has to be noted that in our series 
more than a third of patients of old age achieved a mRS score 
≤3. Although mortality was markedly higher in the elderly, the 
percentage of patients with moderately severe to severe dis-
ability (mRS, 4–5) was not significantly different compared 
to that in younger patients (20.4% versus 14.5%; Figure I in 
the online-only Data Supplement). Apart from a significantly 
higher prevalence of atrial fibrillation in the elderly (n=32/44; 
72.7%; P=0.002), we did not find any significant difference in 
imaging or clinical baseline characteristics, which could have 
acted as possible confounders on outcome.
Fewer patients with extensive ischemic signs in the MCA 
territory showed favorable outcomes (20.6%) and survival at 3 
months (57.4%) compared with those who met standard inclu-
sion criteria, and their sICH rates were markedly increased 
(19.1% versus 3.8%). Percentages of patients with moder-
ately severe to severe disability (mRS, 4–5) were still similar 
in patients with extensive ischemic signs and those with-
out (16.2% versus 15.8%; Figure II in the online-only Data 
Supplement). In our study, none of the patients with an MRI 
ASPECTS ≤3 or a CT ASPECTS ≤4 on pretreatment imaging 
reached a favorable outcome. This is in line with a previous 
report.27 No unequivocally accepted definition of extensive 
ischemic signs in the MCA territory exists in literature. For 
reasons of comparability, we used the ASPECTS-based defi-
nition from the STAR trial.14










Age ≥80 y  
(n=50)
Extensive Ischemic 
Signs in MCA 
Territory (n=69)
Time From Symptom 
Onset to Arterial 
Puncture >8 h (n=22)
sICH, n (%) 22/226 (9.7) 3 (3.7) 1 (3.7) 1 (9.1) 7/49 (14.3) 13/68 (19.1) 2 (9.1)
aICH, n (%) 34/226 (15.0) 15 (18.5) 2 (7.4) 2 (18.2) 5/49 (10.2) 11/68 (16.2) 2 (9.1)
Favorable outcome (mRS, 
0–2) at 3 mo, n (%)
88/221 (39.8) 45/78 (57.7) 20/26 (76.9) 1/10 (10.0) 5/49 (10.2) 14/68 (20.6) 8 (36.4)
Dead at 3 mo, n (%) 57/222 (25.7) 9/79 (11.4) 1/26 (3.8) 5/10 (50.0) 22/49 (44.9) 29/68 (42.6) 4 (18.2)
aICH indicates asymptomatic intracranial hemorrhage; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; 
and sICH, symptomatic intracranial hemorrhage.
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Outcome and survival in patients treated >8 hours after 
symptom onset did not differ from those treated ≤8 hours. 
This is most likely the result of patient selection and empha-
sizes the importance of imaging for treatment decision. We 
treated patients beyond 8 hours only when a considerable 
perfusion-diffusion mismatch and none or only minor signs 
of early ischemic changes were present. Despite the small size 
of this patient subgroup, which precludes from drawing firm 
conclusions, our results are in line with findings from previ-
ously published retrospective studies that showed that endo-
vascular therapy might be used with acceptable safety >6 and 
8 hours, respectively, after stroke onset.28,29
Symptomatic intraprocedural complications occurred in 
only 9 of 227 patients (4.0%). As in other studies with stent 
retrievers, vasospasm necessitating pharmacological spas-
molysis was the most common complication, but it was not 
associated with an elevated risk for sICH or asymptomatic 
intracranial hemorrhage. Distal clot embolization was rarely 
observed (n=15/227 [6.6%]). In 4 of 11 patients (36.6%) 
with emboli directly associated with stent retriever throm-
bectomy, a distal access catheter (Outreach DAC; Concentric 
Medical, Mountain View, CA and VASCO+35 ASPI; Balt, 
Montmorency, France) was used. In 1 of these 4 patients, 
flow arrest was not achieved during stent retrieval because 
the balloon guiding catheter could not be inflated because 
of previous ICA stenting. First, distal access catheters were 
used with the intention to minimize the risk of embolic events 
by shortening the distance, the thrombus had to be retracted 
through the vessel and by providing additional aspiration dur-
ing stent retrieval. Second, they were used to facilitate access 
in patients with tortuous or ectatic vascular anatomy.
In our study, the majority of endovascular interven-
tions (86.3%) were performed under general anesthesia. 
Controversy exists about whether general anesthesia or con-
scious sedation should be preferred in endovascular stroke 
treatment.30–32 In our series, patients undergoing treatment 
with conscious sedation had a significantly higher rate of good 
outcome compared with patients receiving general anesthesia. 
This finding could have been biased by the fact that almost 
all patients with severe stroke (NIHSS score >30 or exten-
sive ischemic signs in the MCA territory) received general 
anesthesia. After exclusion of these patients, the difference in 
favorable outcome between the conscious sedation and gen-
eral anesthesia group was no longer significant.
It has to be noted, that in more than half of the patients, 
other endovascular techniques apart from the Solitaire were 
used to achieve final revascularization. This emphasizes that 
traditional techniques such as intra-arterial thrombolysis or 
thromboaspiration still remain important complementary 
components of endovascular stroke treatment.
Limitations of our study are that data from imaging were 
partly analyzed retrospectively, although clinical data were 
collected prospectively. Moreover, our nonrandomized single-
center study has the inherent limitation of a potential selection 
bias. Furthermore, this is not a randomized study, and only 
indirect comparisons with results of other studies are possible.
Nevertheless, despite limited comparability attributable to 
different revascularization techniques, favorable outcomes in 
patients who met standard inclusion criteria were more frequent 
than in the active arm of PROACT II as well as the endovas-
cular and intravenous thrombolysis arms of Interventional 
Management of Stroke-3.24,33 This finding further supports the 
preferential use of stent retrievers compared with older throm-
bectomy devices or isolated intra-arterial thrombolysis.
Conclusions
Patients <80 years of age, without extensive pretreatment isch-
emic signs on brain imaging, and with a baseline NIHSS score 
≤30 had high rates of favorable outcome and low periproce-
dural complication rates with Solitaire thrombectomy for 
ischemic stroke. Technical success was also high in patients 
not fulfilling standard inclusion criteria, but worse clinical 
outcomes in most of the nonstandard subgroups warrant fur-
ther research to determine more precisely which individuals 
may benefit from stent retriever treatment.
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signs in MCA 
territory (n=69) 
Time from symptom 
onset to arterial puncture 
>8 hours (n=22) 
MRI ASPECTS, 
median (range) 
6 (0─10) 7 (5─10) 7 (4─10) 5 (4─6) 7 (3─10) 3.5 (0─4) 6.5 (3─10) 
CT ASPECTS, 
median (range) 
8 (2─10) 9 (7─10) 10 (9─10) 6 (4─8) 8 (4─10) 5 (0─6) 8.5 (5─10) 
Leptomeningeal 
collaterals 
n=226     n=68  
Good 74 (32.7) 30 (37.0) 14 (51.9) 2 (18.2) 18 (36.0) 9 (13.2) 10 (45.5) 
Moderate 110 (48.7) 41 (50.6) 12 (44.4) 5 (45.5) 19 (38.0) 38 (55.9) 7 (31.8) 
Poor 42 (18.6) 10 (12.3) 1 (3.7) 4 (36.4) 13 (26.0) 21 (30.9) 5 (22.7) 



















signs in MCA 
territory (n=69) 
Time from symptom 
onset to arterial 
puncture >8 hours 
(n=22) 
Reperfusion grade        
TICI 3, n (%) 84 (37.0) 32 (39.5) 11 (40.7) 3 (27.3) 16 (32.0) 24 (34.8) 7 (31.8) 
TICI 2b, n (%) 77 (33.9) 25 (30.9) 12 (44.4) 4 (36.4) 21 (42.0) 19 (27.5) 8 (36.4) 
TICI 2a, n (%) 32 (14.1) 12 (14.8) 3 (11.1) 2 (18.2) 7 (14.0) 13 (18.8) 3 (13.6) 
TICI 1, n (%) 13 (5.7) 7 (8.6) 1 (3.7) 1 (9.1) 0 (0.0) 3 (4.3) 2 (9.1) 
TICI 0, n (%) 21 (9.3) 5 (6.2) 0 (0.0) 1 (9.1) 6 (12.0) 10 (14.5) 2 (9.1) 
Use of distal access catheter 91 (40.1) 28 (34.6) 9 (33.3) 5 (45.5) 17 (34.0) 34 (49.3) 13 (59.1) 
Multimodal endovascular 
therapy 
       
Thromboaspiration, n (%) 63 (27.8) 19 (23.5) 7 (25.9) 2 (18.2) 11 (22.0) 23 (33.3) 10 (45.5) 
Intraarterial thrombolysis 
with urokinase, n (%) 
52 (22.9) 20 (24.7) 8 (29.6) 2 (18.2) 10 (20.0) 17 (24.6) 2 (9.1) 
Stent intracranial 
(Solitaire), n (%) 
8 (3.5) 3 (3.7) 0 (0.0) 1 (9.1) 2 (4.0) 2 (2.9) 3 (13.6) 
Stent intracranial (other), n 
(%) 
4 (1.8) 2 (2.5) 0 (0.0) 1 (9.1) 1 (2.0) 1 (1.4) 0 (0.0) 
Stent extracranial, n (%) 33 (14.5) 13 (16.0) 6 (22.2) 1 (9.1) 0 (0.0) 9 (13.0) 5 (22.7) 
Anesthesia        
General anesthesia, n (%) 196 
(86.3) 
70 (84.4) 16 (59.3) 11 (100) 44 (88.0) 67 (97.1) 19 (86.4) 
Conscious sedation, n (%) 31 (13.7) 11 (13.6) 11 (40.7) 0 (0.0) 6 (12.0) 2 (2.9) 3 (13.6) 



















signs in MCA 
territory (n=69) 
Time from symptom 
onset to arterial 
puncture >8 hours 
(n=22) 
Patients with symptomatic 
intra-procedural 
complications, n (%) 
9 (4.0) 2 (2.5) 2 (7.4) 0 (0.0) 1 (2.0) 4 (5.8) 0 (0.0) 
Total of patients with intra-
procedural complications, n 
(%) 
74 (32.6) 25 (30.9) 8 (29.6) 5 (45.5) 13 (26.0) 23 (33.3) 9 (40.9) 
Occurrence rate of different 
complications 
       
Dissection, n (%) 11 (4.8) 3 (3.7) 1 (3.7) 0 (0.0) 2 (4.0) 4 (5.8) 1 (4.5) 
Vessel perforation, n (%) 2 (0.9) 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.4) 0 (0.0) 
Severe vasospasm, n (%) 43 (18.9) 16 (19.8) 6 (22.2) 2 (18.2) 4 (8.0) 11 (15.9) 7 (31.8) 
In-stent thrombosis, n (%) 8 (3.5) 1 (1.2) 3 (11.1) 1 (9.1) 2 (4.0) 3 (4.3) 0 (0.0) 
Device failure (Solitaire), 
n (%) 
1 (0.4) 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Device failure (other), n 
(%) 
2 (0.9) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.9) 0 (0.0) 
Embolization, n (%) 15 (6.6) 5 (6.2) 0 (0.0) 2 (18.2) 5 (10.0) 6 (8.7) 1 (4.5) 
Immediate reperfusion 
hemorrhage, n (%) 
1 (0.4) 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Other, n (%) 1 (0.4) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.0) 1 (1.4) 0 (0.0) 













Supplementary Figure II. Comparison of 3-month modified Rankin Scale scores of disability between patients with early extensive ischemic signs 
in the MCA territory (n=68) and those without (n=157). 
